December Sees Three Milestones For ViiV’s Pipeline
R&D Chief Outlines 2 FDA Filings, 1 Expected Approval
ViiV Healthcare’s R&D head Kimberly Smith tells Scrip December will see the advancement of three key HIV therapies.
ViiV Healthcare’s R&D head Kimberly Smith tells Scrip December will see the advancement of three key HIV therapies.